[1]
Research criteria for diagnosis of chronic inflammatory demyelinating
polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the
American Academy of Neurology AIDS Task Force. Neurology 1991; 41:
617–618.
[2]
Lunn M.P., Manji H., Choudhary P.P., et al.: Chronic inflammatory demy-
elinating polyneuropthy a prevalence study in south east England. J Neu-
rol Neurosurg Psychiatry 1999; 66: 677–680.
[3]
McLeod J.G., Pollard J.D., Macaskill P., et al.: Prevalence of chronic in-
flammatory demyelinating polyneuropathy in New South Wales, Austra-
lia. Ann Neurol 1999; 46: 910–913.
[4]
Iijima M., Koike H., Hattori N., et al.: Prevalence and incidence rates
of chronic inflammatory demyelinating polyneuropathy in the Japanese
population. J Neurol Neurosurg Psychiatry 2008; 79: 1040–1043.
[5]
European Federation of Neurological Societies/Peripheral Nerve Soci-
ety Guideline on management of paraproteinemic demyelinating neu-
ropathies. Report of a Joint Task Force of the European Federation of
Neurological Societies and the Peripheral Nerve Society – first revision.
J Peripher Nerv Syst 2010; 15: 185–195.
[6]
Rajabally Y.A., Simpson B.S., Beri S., et al.: Epidemiologic variability
of chronic inflammatory demyelinating polyneuropathy with different
diagnostic criteria: study of a UK population. Muscle Nerve 2009; 39:
432–438.
[7]
McMillan H.J., Kang P.B., Jones H.R., et al.: Childhood chronic inflam-
matory demyelinating polyradiculoneuropathy: combined analysis of
a large cohort and eleven published series. Neuromuscul Disord 2013;
23: 103–111.
[8]
Desai J., Ramos-Platt L., Mitchell W.G.: Treatment of pediatric chronic
inflammatory demyelinating polyneuropathy: Challenges, controversies
and questions. Ann Indian Acad Neurol 2015; 18: 327–330.
[9]
Ouvrier R.: Peripheral neuropathies in the young child. Rev Neurol (Paris)
2004; 160: 1216–1220.
[10]
Nevo Y., Pestronk A., Kornberg A.J., et al.: Childhood chronic inflamma-
tory demyelinating neuropathies: clinical course and long-term follow-
up. Neurology 1996; 47: 98–102.
[11]
Ubogu E.E.: Inflammatory neuropathies: pathology, molecular markers
and targets for specific therapeutic intervention. Acta Neuropathol 2015;
130: 445–468.
[12]
Rossignol E., D’Anjou G., Lapointe N., et al.: Evolution and treatment
of childhood chronic inflammatory polyneuropathy. Pediatr Neurol 2007;
36: 88–94.
[13]
Ryan M.M., Grattan-Smith P.J., Procopis P.G., et al.: Childhood chronic in-
flammatory demyelinating polyneuropathy: clinical course and long-term
outcome. Neuromuscul Disord 2000; 10: 398–406.
[14]
Rodriguez-Casero M.V., Shield L.K., Kornberg A.J.: Subacute inflam-
matory demyelinating polyneuropathy in children. Neurology 2005; 64:
1786–1788.
[15]
Hsu C.Y., Chuang Y.C., Chiu N.C., et al.: Childhood subacute inflammatory
demyelinating polyneuropathy. Kaohsiung J Med Sci 2011; 27: 520–523.
[16]
Oh S.J., Kurokawa K., de Almeida D.F., et al.: Subacute inflammatory
demyelinating polyneuropathy. Neurology 2003; 61: 1507–1512.
[17]
Mathey E.K., Park S.B., Hughes R.A., et al.: Chronic inflammatory demy-
elinating polyradiculoneuropathy: from pathology to phenotype. J Neurol
Neurosurg Psychiatry 2015; 86: 973–985.
[18]
Hattori N., Ichimura M., Aoki S., et al.: Clinicopathological features of
chronic inflammatory demyelinating polyradiculoneuropathy in child-
hood. J Neurol Sci 1998; 154: 66–71.
[19]
Ware T.L., Kornberg A.J., Rodriguez-Casero M.V., et al.: Childhood chron-
ic inflammatory demyelinating polyneuropathy: an overview of 10 cases
in the modern era. J Child Neurol 2014; 29: 43–48.
[20]
McDonald D.G., Farrell M.A., McMenamin J.B.: Focal upper limb neu-
ropathy in a child. Eur J Paediatr Neurol 2000; 4: 283–287.
[21]
Nevo Y.: Childhood chronic inflammatory demyelinating polyneuropathy.
Eur J Paediatr Neurol 1998; 2: 169–177.
[22]
Odaka M., Yuki N., Hirata K.: Patients with chronic inflammatory demy-
elinating polyneuropathy initially diagnosed as Guillain-Barré syndrome.
J Neurol 2003; 250: 913–916.
[23]
Rodriguez-Casero M.V., Shield L.K., Coleman L.T., et al.: Childhood chron-
ic inflammatory demyelinating polyneuropathy with central nervous sys
-
tem demyelination resembling multiple sclerosis. Neuromuscul Disord
2003; 13: 158–161.
[24]
Nevo Y., Topaloglu H.: 88th ENMC international workshop: childhood
chronic inflammatory demyelinating polyneuropathy (including revised
diagnostic criteria), Naarden, The Netherlands, December 8–10, 2000.
Neuromuscul Disord 2002; 12: 195–200.
[25]
Thaisetthawatkul P., Logigian E.L., Herrmann D.N.: Dispersion of the
distal compound muscle action potential as a diagnostic criterion for
chronic inflammatory demyelinating polyneuropathy. Neurology 2002;
59: 1526–1532.
[26]
Molenaar D.S., Vermeulen M., de Haan R.: Diagnostic value of sural
nerve biopsy in chronic inflammatory demyelinating polyneuropathy. J
Neurol Neurosurg Psychiatry 1998; 64: 84–89.
[27]
Ryan M.M.: Guillain-Barré syndrome in childhood. J Paediatr Child
Health 2005; 41: 237–241.
[28]
Roodbol J., de Wit M.Y., van den Berg B., et al.: Diagnosis of Guillain-
Barré syndrome in children and validation of the Brighton criteria. J Neu-
rol 2017; 264: 856–861.
[29]
Dionne A., Nicolle M.W., Hahn A.F.: Clinical and electrophysiological
parameters distinguishing acute-onset chronic inflammatory demyelin-
ating polyneuropathy from acute inflammatory demyelinating polyneu-
ropathy. Muscle Nerve 2010; 41: 202–207.
[30]
Ramchandren S., Lewis R.A.: Chronic neuropathies – chronic inflamma-
tory demyelinating neuropathy and its variants. Front Neurol Neurosci
2009; 26: 12–25.
[31]
Mladenovic J., Milic Rasic V., Keckarevic Markovic M., et al.: Epidemiol-
ogy of Charcot-Marie-Tooth disease in the population of Belgrade, Ser
-
bia. Neuroepidemiology 2011; 36: 177–182.
[32]
Berciano J., García A., Combarros O.: Initial semeiology in children with
Charcot-Marie-Tooth disease 1A duplication. Muscle Nerve 2003; 27:
34–39.
[33]
Baba M., Takada H., Tomiyama M., et al.: Chronic inflammatory demy-
elinating polyneuropathy in childhood. No To Shinkei 1993; 45: 233–240.
[34]
Takada H., Baba M., Nunomura J., et al.: Chronic inflammatory demyelin-
ating polyneuropathy in childhood – a case with markedly hypertrophic
nerves and pes cavus. Rinsho Shinkeigaku 1993; 33: 36–39.
[35]
Marques W. Jr., Funayama C.A., Secchin J.B., et al.: Coexistence of two
chronic neuropathies in a young child: Charcot-Marie-Tooth disease type
1A and chronic inflammatory demyelinating polyneuropathy. Muscle
Nerve 2010; 42: 598–600.
[36]
Potulska-Chromik A., Ryniewicz B., Aragon-Gawinska K., et al.: Are elec
-
trophysiological criteria useful in distinguishing childhood demyelinating
neuropathies? J Peripher Nerv Syst 2016; 21: 22–26.
[37]
Connolly A.M.: Chronic inflammatory demyelinating polyneuropathy in
childhood. Pediatr Neurol 2001; 24: 177–182.
[38]
O’Connell S.: Lyme borreliosis: current issues in diagnosis and manage
-
ment. Curr Opin Infect Dis 2010; 23: 231–235.
[39]
Pachner A.R., Steiner I.: Lyme neuroborreliosis: infection, immunity, and
inflammation. Lancet Neurol 2007; 6: 544–552.
[40]
Christen H.J.: Lyme neuroborreliosis in children. Ann Med 1996; 28:
235–240.
[41]
Dudzińska M., Stettner D.: Manifestacje kliniczne neuroboreliozy w ma-
teriale Oddziału Neurologii Dziecięcej w Chorzowie. Neur Dziec 2011; 40:
27–33.
[42]
Vânia Sousa M., Lopes de Carvalho I., Sofia Núncio M., et al.: Meningo
-
myeloradiculitis as an Unusual Presentation of Neuroborreliosis in Child-
hood. Pediatr Infect Dis J 2015; 34: 1132–1133.
[43]
Pachner A.R., Steere A.C.: Neurological findings of Lyme disease. Yale J
Biol Med 1984; 57: 481–483.
[44]
Moroni I., Bugiani M., Ciano C., et al.: Childhood-onset multifocal motor
neuropathy with conduction blocks. Neurology 2006; 66: 922–924.
[45]
Ramdas S., Prasad M., Spillane K., et al.: Acute motor neuropathy with
pure distal involvement – a case report of multifocal motor neuropathy.
Eur J Paediatr Neurol 2013; 17: 415–418.
[46]
Van Asseldonk J.T., Franssen H., Van den Berg-Vos R.M., et al.: Multifo
-
cal motor neuropathy. Lancet Neurol 2005; 4: 309–319.
[47]
Shih H., Gartner J.C. Jr.: Weight loss, hypertension, weakness, and limb
pain in an 11-year-old boy. J Pediatr 2001; 138: 566–569.
[48]
Riekhoff A.G., Jadoul C., Mercelis R., et al.: Childhood chronic inflamma-
tory demyelinating polyneuroradiculopathy – three cases and a review
of the literature. Eur J Paediatr Neurol 2012; 16: 315–331.
[49]
Sladky J.T.: What is the best initial treatment for childhood chronic in-
flammatory demyelinating polyneuropathy: corticosteroids or intrave
-
nous immunoglobulin? Muscle Nerve 2008; 38: 1638–1643.
[50]
Obwieszczenie Ministra Zdrowia z dnia 28 sierpnia 2017 r. w sprawie
wykazu refundowanych leków, środków spożywczych specjalnego prze
-
znaczenia żywieniowego oraz wyrobów medycznych: Załącznik B.67.
Leczenie przetoczeniami immunoglobulin w chorobach neurologicznych.
[51]
Eftimov F., Winer J.B., Vermeulen M., et al.: Intravenous immunoglobu-
lin for chronic inflammatory demyelinating polyradiculoneuropathy. Co
-
chrane Database Syst Rev 2013;(12):CD001797.
[52]
Teasley J.E.: Initial treatment of childhood chronic inflammatory demy-
elinating polyradiculoneuropathy. Muscle Nerve 2008; 38: 1640–1643.
[53]
Rabin M., Mutlu G., Stojkovic T., et al.: Chronic inflammatory demyelin-
ating polyradiculoneuropathy: search for factors associated with treat-
ment dependence or successful withdrawal. J Neurol Neurosurg Psy-
chiatry 2014; 85: 901–906.
[54]
Ripellino P., Fleetwood T., Cantello R., et al.: Treatment of chronic inflam-
matory demyelinating polyneuropathy: from molecular bases to practical
considerations. Autoimmune Dis 2014; 2014:201657.
Scholar Google
PubMed